Yuankui Zhu, Ke Wang, Linghe Yue, Dianbao Zuo, Junfeng Sheng, Sina Lan, . . . Mingqian Feng. (2024). Mesothelin CAR-T cells expressing tumor-targeted immunocytokine IL-12 yield durable efficacy and fewer side effects. Elsevier.
Chicago Style (17th ed.) CitationYuankui Zhu, et al. Mesothelin CAR-T Cells Expressing Tumor-targeted Immunocytokine IL-12 Yield Durable Efficacy and Fewer Side Effects. Elsevier, 2024.
MLA (9th ed.) CitationYuankui Zhu, et al. Mesothelin CAR-T Cells Expressing Tumor-targeted Immunocytokine IL-12 Yield Durable Efficacy and Fewer Side Effects. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.